AJN received this advisory earlier this week from the CDC:

In July 2009, CDC’s Advisory Committee on Immunization Practices (ACIP) made recommendations on who should receive vaccine against novel influenza A (H1N1) when it becomes available, and which priority groups should be vaccinated first if the vaccine is initially available in extremely limited quantities. Five key populations were focused on by the committee to help reduce the impact and spread of novel H1N1. The key populations include those who are at higher risk of disease or complications, those who are likely to come in contact with novel H1N1, and those who could infect young infants. The committee recommends that when the vaccine becomes available, the following groups, accounting for approximately 159 million people in the United States, should receive the vaccine first:

• pregnant women,
• people who live with or care for children younger than 6 months of age,
• health care and emergency services personnel,
• persons between the ages of 6 months through 24 years of age, and
• people from ages 25 through 64 years who are at higher risk for novel H1N1 because of chronic health disorders or compromised immune systems.

The committee does not expect that there will be a shortage of novel H1N1 vaccine, but availability and demand can be unpredictable. There is some possibility that initially the vaccine will be available in limited quantities. In this setting, the committee recommended that the following groups receive the vaccine before […]